Stay updated on Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision: v3.3.2 updated from v3.3.1; no substantive study information is affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-29T03:14:18.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    PubMed auto-fill clarification and a new Revision: v3.3.1 have been added to the Publications section. The previous PubMed auto-fill description and Revision: v3.2.0 text were removed.
    Difference
    0.0%
    Check dated 2025-11-22T02:25:52.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Added a new trial site in Tainan, Taiwan (704) on 2025-11-13, with related updates on 2025-11-06 and 2025-11.
    Difference
    0.2%
    Check dated 2025-11-14T21:20:08.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Added a new NEJM publication entry for MARIPOSA: Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC (N Engl J Med, Oct 30, 2025; DOI: 10.1056/NEJMoa2503001; Epub Sep 7, 2025). Removed the previous 'Online ahead of print' listing for the same article (Sept 7, 2025).
    Difference
    0.0%
    Check dated 2025-11-07T15:13:48.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Core study details (interventions, eligibility criteria, endpoints) appear unchanged between screenshots, with only non-critical metadata differences such as update timestamps visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-10-31T12:04:44.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Added a government funding/status notice and updated version to v3.2.0; removed the old v3.0.2 reference.
    Difference
    2%
    Check dated 2025-10-02T19:46:29.000Z thumbnail image

Stay in the know with updates to Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial page.